Regulus Therapeutics
Why Robinhood?
You can watch RGLS and buy or sell other stocks, ETFs, and their options commission-free!About RGLS
Regulus Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of drugs targeting microRNAs. Its two lead product candidates, RG-012 and RGLS4326, are in clinical development.
RGLS Key Statistics
Stock Snapshot
The current Regulus Therapeutics(RGLS) stock price is $8.16, with a market capitalization of 1.19B.
On 2026-05-09, Regulus Therapeutics(RGLS) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for Regulus Therapeutics(RGLS) stock has reached 0, versus its average volume of 1.25M.
The stock's 52-week range extends from a low of $0.16 to a high of $0.87.
The stock's 52-week range extends from a low of $0.16 to a high of $0.87.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.